|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA07070053
|
Butenylcarnitine
|
(3S)-3-[(2E)-but-2-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 4:1
|
C11H19NO4
|
229.131409
|
|
LMFA01050457
|
(R)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
(3R)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
FA 6:1;O2
|
C6H10O4
|
146.057910
|
|
LMFA01050457
|
(R)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
(3R)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
FA 6:1;O2
|
C6H10O4
|
146.057910
|
|
LMFA01050457
|
(R)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
(3R)-3-hydroxy-3-methyl-2-oxopentanoic acid
|
FA 6:1;O2
|
C6H10O4
|
146.057910
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA01031015
|
mediomycin A
|
(2E,4E,6E,10E,13S,14S,15R,16E,18E,20E,22E,24E,26E,33R,35S,36E,39S,41R,43S,44E,47R,49S,50E,53R,55S)-58-amino-13,15,33,35,39,41,43,47,49,53,55-undecahydroxy-2,12,14,30-tetramethyl-31-oxo-29-(sulfooxy)octapentaconta-2,4,6,10,16,18,20,22,24,26,36,44,50-tridecaenoic acid
|
|
C62H97NO18S
|
1175.642641
|
|
LMFA05000543
|
(2E,4E)-2,4-Decadien-1-ol
|
(2E,4E)-deca-2,4-dien-1-ol
|
FOH 10:2
|
C10H18O
|
154.135765
|
|
LMFA07010991
|
Pentyl heptanoate
|
pentyl heptanoate
|
WE 12:0
|
C12H24O2
|
200.177630
|
|
LMFA12000174
|
7Z-Tetradecen-2-one
|
7Z-Tetradecen-2-one
|
|
C14H26O
|
210.198365
|
|
LMFA04010348
|
ent-7-epi-14-E4c-NeuroP
|
(Z)-6-((1R,2R,3S)-3-hydroxy-2-((R,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA07050224
|
3-hydroxypimeloyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(6-carboxy-3-hydroxyhexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 7:1;O3
|
C28H46N7O20P3S
|
925.173119
|
|
LMFA07050224
|
3-hydroxypimeloyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(6-carboxy-3-hydroxyhexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 7:1;O3
|
C28H46N7O20P3S
|
925.173119
|
|
LMFA07050224
|
3-hydroxypimeloyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(6-carboxy-3-hydroxyhexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 7:1;O3
|
C28H46N7O20P3S
|
925.173119
|
|
LMFA07050224
|
3-hydroxypimeloyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(6-carboxy-3-hydroxyhexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 7:1;O3
|
C28H46N7O20P3S
|
925.173119
|
|
LMFA07050224
|
3-hydroxypimeloyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(6-carboxy-3-hydroxyhexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 7:1;O3
|
C28H46N7O20P3S
|
925.173119
|
|
LMFA07050224
|
3-hydroxypimeloyl-CoA
|
3'-phosphoadenosine 5'-{3-[(3R)-4-{[3-({2-[(6-carboxy-3-hydroxyhexanoyl)sulfanyl]ethyl}amino)-3-oxopropyl]amino}-3-hydroxy-2,2-dimethyl-4-oxobutyl] dihydrogen diphosphate}
|
CoA 7:1;O3
|
C28H46N7O20P3S
|
925.173119
|
|
LMFA07050205
|
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
|
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(3-hydroxy-2,6-dimethyl-5-methylideneheptanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
|
CoA 10:1;O
|
C31H52N7O18P3S
|
935.230239
|
|
LMFA07050205
|
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
|
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(3-hydroxy-2,6-dimethyl-5-methylideneheptanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
|
CoA 10:1;O
|
C31H52N7O18P3S
|
935.230239
|
|
LMFA07050205
|
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
|
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(3-hydroxy-2,6-dimethyl-5-methylideneheptanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
|
CoA 10:1;O
|
C31H52N7O18P3S
|
935.230239
|
|
LMFA07050205
|
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
|
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(3-hydroxy-2,6-dimethyl-5-methylideneheptanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
|
CoA 10:1;O
|
C31H52N7O18P3S
|
935.230239
|
|
LMFA07050205
|
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
|
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(3-hydroxy-2,6-dimethyl-5-methylideneheptanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
|
CoA 10:1;O
|
C31H52N7O18P3S
|
935.230239
|
|
LMFA07050205
|
3-Hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA
|
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-3-{[2-({2-[(3-hydroxy-2,6-dimethyl-5-methylideneheptanoyl)sulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-2,2-dimethylpropoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid
|
CoA 10:1;O
|
C31H52N7O18P3S
|
935.230239
|
|
LMFA07010950
|
Methyl 3-methylbutanoate
|
methyl 3-methylbutanoate
|
SFE 6:0
|
C6H12O2
|
116.083730
|
|
LMFA07010950
|
Methyl 3-methylbutanoate
|
methyl 3-methylbutanoate
|
SFE 6:0
|
C6H12O2
|
116.083730
|
|
LMFA07010933
|
Methyl (R)-3-methyl-2-oxopentanoate
|
methyl 3-methyl-2-oxopentanoate
|
SFE 7:1;O
|
C7H12O3
|
144.078645
|
|
LMFA07010933
|
Methyl (R)-3-methyl-2-oxopentanoate
|
methyl 3-methyl-2-oxopentanoate
|
SFE 7:1;O
|
C7H12O3
|
144.078645
|
|
LMFA07010933
|
Methyl (R)-3-methyl-2-oxopentanoate
|
methyl 3-methyl-2-oxopentanoate
|
SFE 7:1;O
|
C7H12O3
|
144.078645
|
|
LMFA07050379
|
trans-2,3-didehydroadipoyl-CoA
|
6-carboxy-2E-hexenoyl-CoA
|
CoA 6:2;O2
|
C27H42N7O19P3S
|
893.146904
|
|
LMFA07050379
|
trans-2,3-didehydroadipoyl-CoA
|
6-carboxy-2E-hexenoyl-CoA
|
CoA 6:2;O2
|
C27H42N7O19P3S
|
893.146904
|
|
LMFA07050379
|
trans-2,3-didehydroadipoyl-CoA
|
6-carboxy-2E-hexenoyl-CoA
|
CoA 6:2;O2
|
C27H42N7O19P3S
|
893.146904
|
|
LMFA07050379
|
trans-2,3-didehydroadipoyl-CoA
|
6-carboxy-2E-hexenoyl-CoA
|
CoA 6:2;O2
|
C27H42N7O19P3S
|
893.146904
|
|
LMFA07050379
|
trans-2,3-didehydroadipoyl-CoA
|
6-carboxy-2E-hexenoyl-CoA
|
CoA 6:2;O2
|
C27H42N7O19P3S
|
893.146904
|
|
LMFA07050379
|
trans-2,3-didehydroadipoyl-CoA
|
6-carboxy-2E-hexenoyl-CoA
|
CoA 6:2;O2
|
C27H42N7O19P3S
|
893.146904
|
|
LMFA07010711
|
1-Methyl-2-oxopropyl butyrate
|
3-oxobutan-2-yl butanoate
|
SFE 8:1;O
|
C8H14O3
|
158.094295
|
|
LMFA07010711
|
1-Methyl-2-oxopropyl butyrate
|
3-oxobutan-2-yl butanoate
|
SFE 8:1;O
|
C8H14O3
|
158.094295
|
|
LMFA01031142
|
(Z)-16-oxo-octadeca-9,17-dien-12,14-diynoic acid
|
16-oxo-octadeca-9Z,17-dien-12,14-diynoic acid
|
FA 18:7;O
|
C18H22O3
|
286.156895
|
|
LMFA01031142
|
(Z)-16-oxo-octadeca-9,17-dien-12,14-diynoic acid
|
16-oxo-octadeca-9Z,17-dien-12,14-diynoic acid
|
FA 18:7;O
|
C18H22O3
|
286.156895
|
|
LMFA01031142
|
(Z)-16-oxo-octadeca-9,17-dien-12,14-diynoic acid
|
16-oxo-octadeca-9Z,17-dien-12,14-diynoic acid
|
FA 18:7;O
|
C18H22O3
|
286.156895
|
|
LMFA04020041
|
(13S,17S,20R)-d14-16-NeuroF[16S,19S]
|
(S,4Z,7Z,10Z,14E)-13-hydroxy-15-((2S,3S,5S)-3-hydroxy-5-((R)-1-hydroxypropyl)tetrahydrofuran-2-yl)pentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA01020063
|
4-methyl lauric acid
|
4-methyl-dodecanoic acid
|
FA 13:0
|
C13H26O2
|
214.193280
|
|
LMFA04020433
|
(7R,10R,13R)-d8-11-NeuroF[11R,14R]
|
(4Z,7R,8E,10R)-7,10-dihydroxy-10-((2R,4R,5R)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020087
|
(10R,13R,17S)-d15-11-NeuroF[11S,14R]
|
(R,4Z,7Z)-10-hydroxy-10-((2S,4R,5R)-4-hydroxy-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA12000258
|
3-Ethyltridecan-2-one
|
3-Ethyltridecan-2-one
|
|
C15H30O
|
226.229666
|
|
LMFA01140064
|
9-phenyl nonanoic acid
|
9-phenyl-nonanoic acid
|
FA 15:4
|
C15H22O2
|
234.161980
|
|
LMFA01140064
|
9-phenyl nonanoic acid
|
9-phenyl-nonanoic acid
|
FA 15:4
|
C15H22O2
|
234.161980
|
|
LMFA07030007
|
Type IV cyanolipid 18:2 ester
|
(1-cyano-2-methylprop-2-en-1-yl) 9Z,12Z-octadecadienoate
|
|
C23H37NO2
|
359.282429
|
|
LMFA07030007
|
Type IV cyanolipid 18:2 ester
|
(1-cyano-2-methylprop-2-en-1-yl) 9Z,12Z-octadecadienoate
|
|
C23H37NO2
|
359.282429
|